RUBICON RESEARCH (RUBICON) Share Price Falls 3.67% as Large Cap Valuation Stays Rich
- September 3, 2026
- Posted by: Kunal Singla
- Category: News
Rubicon Research Share Price fell today, with the stock last traded at Rs 1,434.65 after declining 3.67% from the previous close. The company’s market capitalisation stood at Rs 24,654.57 crore, keeping Rubicon Research Share Price in the Large Cap category. According to Univest data, the move was a clear intraday price fall rather than a broader multi-day event, and the stock moved lower from the opening level without any company-specific catalyst being established. For readers following Rubicon Research Share Price Today, the key point is the combination of a sharp price move and a valuation profile that remains well above the healthcare industry benchmark. Rubicon Research Share News and Rubicon Research Stock News therefore centre on price action, fundamentals and sector positioning, not on any fresh operational disclosure.
According to latest Univest figures, the decline matters because it changes how Rubicon Research Share Price is viewed against both its own recent trading range and its peer set. The stock touched a low of Rs 1,432.25 and a high of Rs 1,488.30 during the same move, which shows that Rubicon Research Share Price Today stayed below the previous close for most of the interval. That keeps investor attention on valuation, earnings quality and the healthcare context rather than on short-term narrative. Rubicon Research Share Price News Today also needs to be read alongside the company’s high P/E and P/B ratios, since those numbers shape how any price fall is interpreted in a stock analysis frame.
RUBICON RESEARCH (RUBICON) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,434.65 |
| Previous Close | Rs 1,489.35 |
| Today's Move | -Rs 54.70 (-3.67%) |
| Open | Rs 1,484.6 |
| High | Rs 1,488.3 |
| Low | Rs 1,432.25 |
| Market Capitalisation | Rs 24,654.57 crore |
| Market Cap Category | Large Cap |
Rubicon Research Share Price Today opened at Rs 1,484.60, moved to a high of Rs 1,488.30 and a low of Rs 1,432.25, and last traded at Rs 1,434.65. That places the stock Rs 54.70 below the previous close of Rs 1,489.35, or down 3.67% on the day. Rubicon Research Share Price therefore showed a clear intraday price fall, with the day’s range remaining relatively tight around the opening zone before drifting toward the low. The market capitalisation of Rs 24,654.57 crore keeps Rubicon Research Share Price in the Large Cap bracket, which is useful context for the scale of the move. For Rubicon Research Share Price Live tracking, the main factual takeaway is simple: the stock was weaker from the opening and stayed under pressure through the quoted range. That sets up the Rubicon Research Fundamental Analysis section.
Rubicon Research Share Price also matters because the current level is only modestly above the day’s low and still below the previous close. Rubicon Research Share Price Today is therefore a price-action event first, with the next layer of analysis coming from valuation, profitability and sector comparison.
RUBICON RESEARCH (RUBICON) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 24,654.57 crore |
| P/E Ratio | 85.54x |
| P/B Ratio | 18.37x |
| ROE | 27.84% |
| ROCE | 29.22% |
| EPS | Rs 17.41 |
| Book Value Per Share | Rs 81.09 |
| Dividend Yield | 0.1% |
RUBICON RESEARCH (RUBICON) fundamental metrics show P/E 85.54x, P/B 18.37x, ROE 27.84%, ROCE 29.22%. These ratios show where the company stands today and are not a call to buy or sell.
RUBICON RESEARCH has a market capitalisation of Rs 24,654.57 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 85.54x, P/B at 18.37x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.84% and ROCE of 29.22%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 17.41, book value per share of Rs 81.09, dividend yield of 0.1%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.73x, median ROE of 11.33%, median ROCE of 13.25%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 85.54x |
| Benchmark Median P/E | 31.73x |
| Benchmark Average P/E | 45.98x |
| Benchmark P/E Range | 3.1x to 616.89x |
| Company P/B Ratio | 18.37x |
| Benchmark Median P/B | 2.76x |
| Benchmark Average P/B | 4.11x |
| Company ROE | 27.84% |
| Benchmark Median ROE | 11.33% |
| Benchmark Average ROE | 10.14% |
| Company ROCE | 29.22% |
| Benchmark Median ROCE | 13.25% |
| Benchmark Average ROCE | 13.05% |
| Company Market Capitalisation | Rs 24,654.57 crore |
| Benchmark Median Market Cap | Rs 771.43 crore |
| Benchmark Average Market Cap | Rs 13,467.03 crore |
RUBICON RESEARCH (RUBICON) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
RUBICON RESEARCH (RUBICON) has a P/E ratio of 85.54x, which is above the benchmark median of 31.73x, a difference of +169.59%. A P/E difference of this kind is a reference point rather than a recommendation.
RUBICON RESEARCH (RUBICON) has a ROE of 27.84%, which is above the benchmark median of 11.33%, a difference of +145.72%. RUBICON RESEARCH (RUBICON) has a ROCE of 29.22%, which is above the benchmark median of 13.25%, a difference of +120.53%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,18,683.95 | 34.61 | 4.84 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,41,310.94 | 82.5 | 13.66 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,73,078.79 | 79.36 | 19.28 | 26.76 | 19.27 |
| Laurus Labs | LAURUSLABS | 1,11,433.99 | 101.92 | 19.76 | 18.31 | 18.2 |
| Zydus Lifesciences | ZYDUSLIFE | 1,11,022.18 | 24.6 | 4.12 | 19.69 | 21.39 |
RUBICON RESEARCH (RUBICON) has a P/E ratio of 85.54x compared with the displayed peer median of 79.36x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 27.84% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 29.22% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. RUBICON RESEARCH (RUBICON) has a market capitalisation of Rs 24,654.57 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Rubicon Research
- Rubicon Research Share Price fell 3.67% to Rs 1,434.65, making the day’s price action the first item investors are checking.
- Rubicon Research Share Price Today sits below the previous close of Rs 1,489.35, with the low touching Rs 1,432.25.
- Rubicon Research Share Price has a P/E of 85.54 and a P/B of 18.37, both well above the same-industry benchmark.
- Rubicon Research Share Price shows ROE of 27.84% and ROCE of 29.22%, which are stronger than industry medians and averages.
- Rubicon Research Share Price News also stands out because the company is a Large Cap with market capitalisation of Rs 24,654.57 crore.
About Rubicon Research
Rubicon Research is part of the Healthcare sector and operates in the Pharmaceuticals & Drugs industry. Its Rubicon Research Share Price is often tracked alongside peers because the company sits in a valuation-heavy part of the market. The available financial profile points to a business with strong returns on capital, as reflected in ROE and ROCE, while the book value and EPS give a basic picture of the earnings and net-worth base behind the stock. Rubicon Research Share News is therefore closely linked to both company performance and the wider pharmaceutical valuation framework. For investors using Rubicon Research Stock News as a monitor, the company’s scale and pricing remain central to the discussion.
Track Rubicon Research Share Price on Univest
Use RUBICON RESEARCH (RUBICON) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Rubicon Research Share Price on Univest for live updates, valuation ratios, market capitalisation, 52-week levels and sector insights. Univest also helps readers compare Rubicon Research Share Price Today with peer benchmarks, fundamental ratios and broader healthcare context. For Rubicon Research Share Price News, that makes it easier to follow price action and financial analysis in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Rubicon Research Share Price falling today?
Ans. Rubicon Research Share Price fell 3.67% to Rs 1,434.65, with no company-specific catalyst established. The move is confirmed by the day’s open, high, low and previous close, which show a clear intraday decline.
What is Rubicon Research Share Price Today?
Ans. Rubicon Research Share Price Today last traded at Rs 1,434.65, compared with the previous close of Rs 1,489.35. The stock moved between Rs 1,432.25 and Rs 1,488.30 during the quoted move.
What is Rubicon Research Share Price market capitalisation?
Ans. Rubicon Research Share Price is supported by a market capitalisation of Rs 24,654.57 crore. That places the company in the Large Cap category and gives context to its valuation, peer position and sector comparison.
How do Rubicon Research valuation ratios look?
Ans. Rubicon Research Share Price is trading at a P/E of 85.54 and a P/B of 18.37. Both are above the same-industry median and average, so the stock is priced at a premium to its healthcare benchmark.
What do ROE and ROCE say about Rubicon Research Share Price?
Ans. Rubicon Research Share Price is backed by ROE of 27.84% and ROCE of 29.22%. Both are above the same-industry medians and averages, which indicates a stronger return profile than the broader peer set.
What is Rubicon Research EPS and book value?
Ans. Rubicon Research Share Price includes EPS of Rs 17.41 and book value of Rs 81.09 per share. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share.
How does Rubicon Research compare with healthcare peers?
Ans. Rubicon Research Share Price has a higher P/E and P/B than most peers in the comparison set, while its ROE and ROCE are also strong. That combination makes the valuation richer than many listed pharma names.
Is Rubicon Research Share Price part of the Healthcare sector?
Ans. Yes, Rubicon Research Share Price belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That matters because the company is compared with a large benchmark universe of 199 same-industry companies.
Where can investors track Rubicon Research Share Price on Univest?
Ans. Investors can track Rubicon Research Share Price on Univest for live pricing, valuation ratios, 52-week levels and market insights. The platform also helps compare the stock with peer valuations and sector benchmarks.
